Cite

HARVARD Citation

    Rovithi, M. et al. (2016). Response and toxicity prediction by MALDI‐TOF‐MS serum peptide profiling in patients with non‐small cell lung cancer. Proteomics. 10 (7), pp. 743-749. [Online]. 
  
Back to record